Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

The microarray way to tailored cancer treatment

Indistinguishable disease states in diffuse large B-cell lymphoma unraveled by microarray expression profiles: A new basis for therapy selection. (pages 68–74)

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Morphologically recognised variants of DLBCL do not predict outcome of disease.

References

  1. Shipp, M.A. et al. Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nature Med. 8, 68–74 (2002).

    Article  CAS  Google Scholar 

  2. Shipp, M.A. et al. A predictive model for aggressive non-Hodgkin's Lymphoma. New Engl. J. Med. 329, 987–994 (1993).

    Article  Google Scholar 

  3. Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).

    Article  CAS  Google Scholar 

  4. Quackenbush, J. Computational analysis of microarray data. Nature Rev. Genet. 2, 418–427 (2001).

    Article  CAS  Google Scholar 

  5. Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536–540 (2000).

    Article  CAS  Google Scholar 

  6. Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).

    Article  CAS  Google Scholar 

  7. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869–10874 (2001).

    Article  CAS  Google Scholar 

  8. Scherf, U. et al. A gene expression database for the molecular pharmacology of cancer. Nature Genet. 24, 236–244 (2000).

    Article  CAS  Google Scholar 

  9. Fisher R.I. et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New Engl. J. Med. 328, 1002–1006 (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van't Veer, L., De Jong, D. The microarray way to tailored cancer treatment. Nat Med 8, 13–14 (2002). https://doi.org/10.1038/nm0102-13

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0102-13

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing